FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 56 filers reported holding FORTRESS BIOTECH INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $387 | +2.4% | 450 | 0.0% | 0.00% | – |
| Q2 2022 | $378 | -38.2% | 450 | 0.0% | 0.00% | – |
| Q1 2022 | $612 | -45.6% | 450 | 0.0% | 0.00% | – |
| Q4 2021 | $1,125 | -22.4% | 450 | 0.0% | 0.00% | – |
| Q3 2021 | $1,449 | -9.8% | 450 | 0.0% | 0.00% | – |
| Q2 2021 | $1,607 | +1.1% | 450 | 0.0% | 0.00% | – |
| Q1 2021 | $1,589 | +11.4% | 450 | 0.0% | 0.00% | – |
| Q4 2020 | $1,427 | -21.5% | 450 | 0.0% | 0.00% | – |
| Q3 2020 | $1,818 | +50.7% | 450 | 0.0% | 0.00% | – |
| Q2 2020 | $1,206 | +41.7% | 450 | 0.0% | 0.00% | – |
| Q1 2020 | $851 | -26.4% | 450 | 0.0% | 0.00% | – |
| Q4 2019 | $1,157 | +82.2% | 450 | 0.0% | 0.00% | – |
| Q3 2019 | $635 | -5.9% | 450 | 0.0% | 0.00% | – |
| Q2 2019 | $675 | -15.7% | 450 | 0.0% | 0.00% | – |
| Q1 2019 | $801 | +107.0% | 450 | 0.0% | 0.00% | – |
| Q4 2018 | $387 | -46.2% | 450 | 0.0% | 0.00% | – |
| Q3 2018 | $720 | -46.3% | 450 | 0.0% | 0.00% | – |
| Q2 2018 | $1,341 | -34.5% | 450 | 0.0% | 0.00% | – |
| Q1 2018 | $2,048 | +14.0% | 450 | 0.0% | 0.00% | – |
| Q4 2017 | $1,796 | – | 450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,830,000 | $10,264,000 | 2.07% |
| SHIKIAR ASSET MANAGEMENT INC | 345,500 | $926,000 | 0.42% |
| Nantahala Capital Management | 4,424,938 | $11,859,000 | 0.36% |
| FNY Investment Advisers, LLC | 175,000 | $469,000 | 0.27% |
| Telemetry Investments, L.L.C. | 20,376 | $55,000 | 0.15% |
| CPWM, LLC | 406,267 | $1,089,000 | 0.12% |
| 683 Capital Management, LLC | 200,000 | $536,000 | 0.04% |
| B. Riley Wealth Advisors, Inc. | 57,491 | $154,000 | 0.01% |
| Walleye Capital LLC | 15,000 | $40,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 720,803 | $1,932,000 | 0.01% |